Ombay, Bonita F.
HRN: 04-84-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2025
CLINDAMYCIN 300MG (CAP)
03/25/2025
03/26/2025
IV
900mg
Q8h X3 Doses
SP RLTCS W/ BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes